[F2] Flash Talks (Even No.)

9:35 AM - 9:36 AM JST(12:35 AM - 12:36 AM UTC)

[F-12] Prime-Push Mtb Vaccination Drives Immuno-Switching in the Tumor Microenvironment

*BURCU TEMIZOZ^1,2,6,7, Nobuyoshi Kobayashi^2,3, Yuta Ohira^2,3, Kou Hioki¹, Mai Onaga¹, Tomoya Hayashi^1,2,6,7, Michelle Sue Jann Lee⁵, Takayuki Horii³, Cevayir Coban^4,5,6,7, Kouji Kobiyama^1,2,6,7, Ken J Ishii^1,2,4,6,7 (1. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), 4-6-1, Tokyo, Japan (Japan), 2. Center for Adjuvant and Vaccine Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8, Osaka, Japan (Japan), 3. Central Research Laboratories, Zeria Pharmaceutical Co., Ltd., 2512-1 Numagami, Oshikiri, Kumagaya-shi, Saitama, Japan (Japan), 4. WPI Immunology Frontier Research Center (IFReC), Osaka University, 3-3-1, Osaka, Japan (Japan), 5. Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1, Tokyo, Japan (Japan), 6. International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, 4-6-1, Tokyo, Japan (Japan), 7. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo 108-8639, Japan. (Japan))

Keywords:

MX,Mycobacterium tuberculosis extract,Treg,CD4 CTL

Password required to view

Log in

or